Annual Net Income
-$99.92 M
-$213.78 M-187.75%
01 December 2023
Summary:
Sinovac Biotech annual net profit is currently -$99.92 million, with the most recent change of -$213.78 million (-187.75%) on 01 December 2023. During the last 3 years, it has fallen by -$210.29 million (-190.53%). SVA annual net income is now -101.18% below its all-time high of $8.47 billion, reached on 31 December 2021.SVA Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
N/A
01 June 2024
Summary:
Sinovac Biotech quarterly net profit is not available.SVA Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
N/A
01 June 2024
Summary:
Sinovac Biotech TTM net profit is not available.SVA TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SVA Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -190.5% | - | - |
| 5 y5 years | -558.7% | - | - |
SVA Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -101.2% | at low | ||||
| 5 y | 5 years | -101.2% | at low | ||||
| alltime | all time | -101.2% | at low |
Sinovac Biotech Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$99.92 M(-187.8%) | - | - |
| Dec 2022 | $113.87 M(-98.7%) | - | - |
| Dec 2021 | $8.47 B(+7572.0%) | - | - |
| Dec 2020 | $110.37 M(+145.7%) | $108.83 M(+875.1%) | $110.37 M(+346.2%) |
| Sept 2020 | - | $11.16 M(-396.8%) | $24.73 M(+15.8%) |
| June 2020 | - | -$3.76 M(-35.9%) | $21.37 M(-42.7%) |
| Mar 2020 | - | -$5.86 M(-125.3%) | $37.28 M(-17.0%) |
| Dec 2019 | $44.93 M(+106.3%) | $23.20 M(+197.6%) | $44.93 M(+118.4%) |
| Sept 2019 | - | $7.79 M(-35.9%) | $20.57 M(-4.9%) |
| June 2019 | - | $12.15 M(+579.2%) | $21.64 M(+42.2%) |
| Mar 2019 | - | $1.79 M(-253.6%) | $15.21 M(-30.2%) |
| Dec 2018 | $21.78 M(-15.6%) | -$1.17 M(-113.1%) | $21.78 M(-5.1%) |
| Sept 2018 | - | $8.86 M(+54.8%) | $22.95 M(+62.9%) |
| June 2018 | - | $5.72 M(-31.5%) | $14.09 M(+68.5%) |
| Mar 2018 | - | $8.36 M(+87.9%) | $8.36 M(-1502.7%) |
| Dec 2017 | $25.81 M(-4430.0%) | - | - |
| Dec 2016 | -$596.00 K(-57.9%) | $4.45 M(+38.8%) | -$596.00 K(-87.8%) |
| Sept 2016 | - | $3.21 M(-133.5%) | -$4.88 M(-49.6%) |
| June 2016 | - | -$9.56 M(-830.3%) | -$9.69 M(-552.0%) |
| Mar 2016 | - | $1.31 M(+708.0%) | $2.14 M(-251.2%) |
| Dec 2015 | -$1.42 M(-6.5%) | $162.00 K(-110.1%) | -$1.42 M(+50.9%) |
| Sept 2015 | - | -$1.60 M(-170.4%) | -$939.00 K(-225.5%) |
| June 2015 | - | $2.27 M(-200.8%) | $748.00 K(-119.8%) |
| Mar 2015 | - | -$2.25 M(-451.7%) | -$3.77 M(+148.8%) |
| Dec 2014 | -$1.51 M(-120.4%) | $640.00 K(+619.1%) | -$1.51 M(-141.3%) |
| Sept 2014 | - | $89.00 K(-104.0%) | $3.67 M(-37.7%) |
| June 2014 | - | -$2.25 M(<-9900.0%) | $5.89 M(-37.7%) |
| Mar 2014 | - | $4000.00(-99.9%) | $9.46 M(+27.0%) |
| Dec 2013 | $7.44 M(-150.1%) | $5.82 M(+152.0%) | $7.44 M(-349.1%) |
| Sept 2013 | - | $2.31 M(+75.1%) | -$2.99 M(-64.0%) |
| June 2013 | - | $1.32 M(-165.7%) | -$8.30 M(-26.2%) |
| Mar 2013 | - | -$2.01 M(-56.4%) | -$11.25 M(-24.3%) |
| Dec 2012 | -$14.85 M(+1659.8%) | -$4.61 M(+53.5%) | -$14.85 M(+98.7%) |
| Sept 2012 | - | -$3.00 M(+84.1%) | -$7.48 M(+13.0%) |
| June 2012 | - | -$1.63 M(-71.0%) | -$6.62 M(+80.7%) |
| Mar 2012 | - | -$5.61 M(-302.7%) | -$3.66 M(+333.9%) |
| Dec 2011 | -$844.00 K | $2.77 M(-229.3%) | -$844.00 K(-93.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2011 | - | -$2.14 M(-261.8%) | -$12.56 M(+17.2%) |
| June 2011 | - | $1.32 M(-147.4%) | -$10.72 M(-2.5%) |
| Mar 2011 | - | -$2.79 M(-68.8%) | -$11.00 M(+29.2%) |
| Dec 2010 | -$8.51 M(-142.6%) | -$8.95 M(+2906.7%) | -$8.51 M(-191.1%) |
| Sept 2010 | - | -$297.60 K(-128.5%) | $9.34 M(-37.2%) |
| June 2010 | - | $1.05 M(-440.2%) | $14.86 M(-24.3%) |
| Mar 2010 | - | -$307.30 K(-103.5%) | $19.63 M(-1.7%) |
| Dec 2009 | $19.96 M(+149.2%) | $8.90 M(+70.3%) | $19.96 M(+48.6%) |
| Sept 2009 | - | $5.23 M(-10.0%) | $13.43 M(+50.1%) |
| June 2009 | - | $5.81 M(>+9900.0%) | $8.95 M(+38.2%) |
| Mar 2009 | - | $24.70 K(-99.0%) | $6.47 M(-19.2%) |
| Dec 2008 | $8.01 M(+4.7%) | $2.37 M(+220.9%) | $8.01 M(+5.0%) |
| Sept 2008 | - | $739.90 K(-77.8%) | $7.63 M(-16.0%) |
| June 2008 | - | $3.34 M(+113.9%) | $9.08 M(+21.4%) |
| Mar 2008 | - | $1.56 M(-21.7%) | $7.48 M(-2.3%) |
| Dec 2007 | $7.65 M(-1199.2%) | $1.99 M(-9.0%) | $7.65 M(+39.5%) |
| Sept 2007 | - | $2.19 M(+26.3%) | $5.48 M(+75.8%) |
| June 2007 | - | $1.73 M(0.0%) | $3.12 M(+246.3%) |
| Mar 2007 | - | $1.73 M(-1096.3%) | $900.60 K(-168.3%) |
| Dec 2006 | -$696.00 K(-86.4%) | -$174.00 K(0.0%) | -$1.32 M(-33.0%) |
| Sept 2006 | - | -$174.00 K(-64.1%) | -$1.97 M(-24.8%) |
| June 2006 | - | -$484.90 K(0.0%) | -$2.62 M(-32.3%) |
| Mar 2006 | - | -$484.90 K(-41.1%) | -$3.86 M(-24.4%) |
| Dec 2005 | -$5.11 M(+9.5%) | -$822.60 K(0.0%) | -$5.11 M(+11.4%) |
| Sept 2005 | - | -$822.60 K(-52.5%) | -$4.59 M(-12.5%) |
| June 2005 | - | -$1.73 M(0.0%) | -$5.24 M(+5.8%) |
| Mar 2005 | - | -$1.73 M(+475.3%) | -$4.95 M(+6.2%) |
| Dec 2004 | -$4.67 M(+435.0%) | -$301.20 K(-79.6%) | -$4.67 M(+391.4%) |
| Sept 2004 | - | -$1.48 M(+2.2%) | -$949.60 K(+220.8%) |
| June 2004 | - | -$1.44 M(0.0%) | -$296.00 K(-125.8%) |
| Mar 2004 | - | -$1.44 M(-142.3%) | $1.15 M(-55.7%) |
| Dec 2003 | -$872.30 K(+400.7%) | $3.42 M(-515.2%) | $2.59 M(-415.2%) |
| Sept 2003 | - | -$822.60 K | -$822.60 K |
| Apr 2002 | -$174.20 K(-64.1%) | - | - |
| Apr 2001 | -$484.60 K(+21.9%) | - | - |
| Apr 2000 | -$397.40 K(+6013.8%) | - | - |
| Apr 1999 | -$6500.00 | - | - |
FAQ
- What is Sinovac Biotech annual net profit?
- What is the all time high annual net income for Sinovac Biotech?
- What is the all time high quarterly net income for Sinovac Biotech?
- What is the all time high TTM net income for Sinovac Biotech?
What is Sinovac Biotech annual net profit?
The current annual net income of SVA is -$99.92 M
What is the all time high annual net income for Sinovac Biotech?
Sinovac Biotech all-time high annual net profit is $8.47 B
What is the all time high quarterly net income for Sinovac Biotech?
Sinovac Biotech all-time high quarterly net profit is $108.83 M
What is the all time high TTM net income for Sinovac Biotech?
Sinovac Biotech all-time high TTM net profit is $110.37 M